Introduction
Osteoblasts are bone cells that originate from mesenchymal stem cells. They are cuboidal and located along the bone surface. The expression of specific genes, such as bone morphogenetic proteins, Wnt, runt-related transcription factor 2, osterix, alkaline phosphatase (ALP), and others, is key to osteoblast differentiation.1,2 Osteoblasts synthesize the bone matrix, which is important for responding to gravitational forces and for intercellular communication.3 Bone also has a high capacity for remodeling, a complex cycle of cellular events controlled by local and systemic factors.1 Matrix metalloproteinases (MMPs) also play a significant role in embryonic growth and development, contributing to tissue morphogenesis and organogenesis by remodeling the extracellular matrix.4 They are extensively involved in both physiological and pathological processes and regulate crucial biological mechanisms, including angiogenesis, embryogenesis, dynamic tissue remodeling, growth, and aging.5 Physiologically, MMPs play a vital role in bone homeostasis.6 MMP-2 contributes to bone remodeling. Additionally, MMP-9 is involved in various biological processes, including cell-surface protein cleavage, extracellular matrix degradation, cleavage of proteins and peptides in the extracellular environment, and modification of cell-cell and cell-extracellular matrix interactions.7
Fractures are an important health concern among older adults in the United States.8 As life expectancy increases, the incidence of bone fractures among older adults is expected to rise, representing an important and costly public health problem.9,10
Given this, natural products have been studied as therapeutic approaches and as alternatives in tissue engineering to minimize side effects in bone repair.9 Many studies have shown that plant-derived substances combined with scaffolds may improve the bioactivity of biomaterials for osteogenic differentiation.11 Previous studies suggest that some plant-derived biomaterials have osteoconductive properties and act in repair mechanisms. For example, acemannan, a fraction of Aloe vera gel, demonstrated upregulation of osteogenesis-related gene expression when primary periodontal ligament cells were treated with it.12
Qualea grandiflora Mart. (QG) is commonly known as “pau-terra,” “pau-terra-do-campo,” “pau-terra-do-cerrado,” “pau-terra-da-folha-larga,” “ariavá,” among other names.13,14 It is among the most widespread tree species in the Cerrado.15 The literature indicates that extracts from QG leaves have depressant effects on the central nervous system and exhibit analgesic and anticonvulsant properties.16 Cordeiro et al.17 reported that QG has antiprotozoal activity and no cytotoxicity against L-6 cells (IC50 > 100 μg/mL). Furthermore, Pires et al.18 reported antimicrobial activity against Streptococcus mutans at a concentration of 5 mg/mL. The ethanolic extract of QG bark shows antiulcer activity,14 and studies of its methanolic bark extract have shown antibacterial activity against Staphylococcus aureus, Bacillus cereus, and Pseudomonas aeruginosa.19 However, research on the application of QG in bone cells remains limited, although the potential healing effects of crude ethanolic QG extract were evaluated in the alveoli of rats with induced dental alveolitis. QG was associated with bone formation comparable to that observed with the commercially used drug.20
Therefore, this study aimed to investigate the effects of a hydroalcoholic QG leaf extract on preosteoblast function in the MC3T3-E1 cell line.21 Given the substantial global burden of fractures among older adults,22 an alternative with bone-forming properties could be promising.
Materials and methods
Preosteoblasts
The MC3T3-E1 (subclone 4) preosteoblast cell line derived from mouse calvaria was obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA). It was maintained at 37°C in Minimum Essential Medium alpha (α-MEM; Gibco, CA, USA) supplemented with 10% fetal bovine serum (FBS; Gibco, NY, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin in a humidified atmosphere with 5% CO2.23 The medium was changed every 3 days. The cells were subcultured when the flask became subconfluent using 0.25% trypsin-EDTA (Sigma-Aldrich, USA). The cells were then plated for the assays, and the experiments were performed in triplicate, except for the MTT assay, which was performed in quintuplicate; independently repeated three times.
Qualea grandiflora
QG leaves were collected at the Bauru Municipal Botanic Garden (S 22° 18′ 54′′, W 49° 3′ 39′′) in November 2018. The voucher specimen was deposited in the Herbarium of the Department of Biological Sciences at UNESP (UNBA6034), and the collection was approved by SISBIO under permit No. 39825-1. The extraction procedures were previously described by Oliveira et al.24 The plant name was verified on the website http://www.theplantlist.org/tpl1.1/record/kew-2868182 on August 28, 2021.
Cell viability assay
Cells were seeded in 96-well plates at 3 × 103 cells per well in α-MEM supplemented with 10% FBS. After adhesion, the cells were treated with QG extract (0.1, 1.0, or 10.0 μg/mL) or control medium (α-MEM with 10% FBS). Cell metabolic activity was measured at 24, 48, and 72 h using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cells were washed with phosphate-buffered saline (PBS) and then incubated with MTT solution (0.5 mg/mL) for 4 h at 37°C. Dimethyl sulfoxide was added afterward, and absorbance was measured at 550 nm using a spectrophotometer (Fluostar OPTIMA, BMG Labtech, Offenburg, Germany).25,26
Alkaline phosphatase activity
A total of 2 × 104 cells were plated in 24-well plates in triplicate. After 24 h of adhesion, the medium was replaced with osteogenic medium containing α-MEM, 10% FBS, 50 μg/mL ascorbic acid, and 10 mM β-glycerophosphate; QG extract (0.1, 1.0, or 10.0 μg/mL) or control medium was then added. On days 7, 10, and 14, the cells were washed with PBS, and lysis buffer (10 mM Tris, pH 7.5, 0.5 mM MgCl2, and 0.1% Triton X-100) was added. The cell lysate was collected and centrifuged at 14,000 rpm for 15 min at 4°C. The supernatants were used to determine ALP activity.27
Calcium nodule formation
Mineralization was assessed using alizarin red staining (Sigma). Cells at a density of 4 × 105 cells per well were plated in 12-well plates in triplicate and cultured in osteogenic medium with QG extract (0.1, 1.0, or 10.0 μg/mL) or control medium; the medium was replaced every 3 days. After 21 days, the supernatants were removed, and the cells were washed with PBS and fixed with 4% formaldehyde for 5 min at room temperature. The cells were then incubated with 2% alizarin red solution at pH 4.2 for 10 min, followed by three washes with ultrapure water. Quantitative analysis was performed using a colorimetric method. In the dried, stained microplate, 10% acetic acid was added for 30 min with agitation at room temperature. The contents of each well were heated at 85°C for 10 min and then kept on ice for 5 min before centrifugation at 20,000 × g for 15 min. Then, 100 μL of the supernatant was transferred to 96-well plates, and 10% ammonium hydroxide was added to neutralize the acid. Absorbance was measured at 405 nm.25,28
Gene expression by quantitative polymerase chain reaction (qPCR)
A total of 5 × 105 cells were seeded in 6-well plates in triplicate. After adhesion, QG extract (0.1, 1.0, or 10.0 μg/mL) or control medium was added to the wells. After 24 and 48 h of treatment, messenger RNA was extracted using the RNeasy Mini Kit (spin column) with DNase (Qiagen) and reverse-transcribed into cDNA using the RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific) according to the manufacturer’s recommendations. The cDNA samples were incubated with SensiMix Hi-Rox SYBR Green (Bioline) and analyzed on the ViiA 7 Real-Time PCR System (Applied Biosystems). qPCR amplification was performed using the following primer sets, with GAPDH used to normalize the results: Mmp2 (ACAGGACATTGTCTTTGATG/TACACAGCGTCAATCTTTTC); Mmp9 (CTTCCAGTACCAAGACAAAG/ACCTTGTTCACCTCATTTTG); and GAPDH (TGGCAAAGTGGAGATTGTTGC/AAGATGGTGATGGGCTTCCCG).26,29
MMP-2 and MMP-9 expression by western blotting
Cells were plated in 100 × 20 mm Petri dishes at a density of 1 × 106 cells in triplicate. After treatment with QG extract (0.1, 1.0, or 10.0 μg/mL) or control medium for 24 or 48 h, the cells were lysed with a buffer solution containing 50 mM Tris-HCl (pH 7.4), 25 mM KCl, 5 mM MgCl2, and 0.2% Nonidet P-40 supplemented with protease inhibitors (Sigma-Aldrich) and phosphatase inhibitor (0.2 M sodium orthovanadate; Calbiochem). The lysate was pooled, sonicated, and centrifuged at 14,000 rpm for 10 min at 4°C. Protein samples (50 µg) were subjected to electrophoresis on a 10% Tris-HCl polyacrylamide gel and subsequently transferred to a polyvinylidene difluoride membrane. The membrane was immunolabeled with goat polyclonal anti-MMP-2 and anti-MMP-9 primary antibodies (sc-6838; sc-6840, Santa Cruz Biotechnology), followed by secondary anti-goat IgG conjugated to horseradish peroxidase (sc-2354, Santa Cruz Biotechnology). Rabbit polyclonal anti-β-actin (sc-130657; Santa Cruz Biotechnology) was used as an endogenous control, followed by secondary anti-rabbit IgG conjugated to horseradish peroxidase (sc-2357, Santa Cruz Biotechnology). Enhanced chemiluminescence reagent (Amersham Biosciences) was used for detection, and the band densities were determined by densitometric analysis using Image Studio Lite software (LI–COR, Lincoln, Nebraska, USA) and ImageJ software (National Institutes of Health, NIH Image). The density values obtained were corrected by subtracting the background values.25,30
MMP-2 and MMP-9 activity
A total of 2 × 106 cells were plated in a 100 × 20 mm Petri dish. After 24 h of adhesion, QG extract (0.1, 1.0, or 10.0 μg/mL) was added, along with a control group. After 24 and 48 h of incubation, the supernatant was collected, concentrated using Amicon tubes, and centrifuged at 14,000 rpm for approximately 30 min or until the volume reached 150 μL. Then, 50 µg of protein was loaded onto the zymography gel. Molecular-weight standards and recombinant hrMMP-2 and hrMMP-9 proteins (Calbiochem; Merck, Darmstadt, Germany) were used as controls. The gels were stained with Coomassie Blue G-250 (0.5%) and scanned using the Loccus Biotecnologia DS-6000, followed by analysis in Lab Image 1D software. Gel degradation was determined by densitometric analysis using ImageJ software (National Institutes of Health, NIH Image). Only active MMP bands were quantified, and densitometric values were normalized to the corresponding control group.25
Statistical analysis
The results were analyzed using GraphPad Prism 5 software (La Jolla, USA). The groups were subjected to one-way analysis of variance with Tukey’s test, and normality was assessed using the Kolmogorov-Smirnov test. Statistical significance was set at P < 0.05. A sample size of n = 5 was used for the MTT assay, and n = 3 for ALP activity, alizarin red staining, qPCR, western blotting, and zymography.
Results
Effects of QG on MC3T3-E1 metabolic activity, differentiation, and mineralization
We assessed MTT metabolic activity (Fig. 1a). At 24 h, metabolic activity at 0.1 μg/mL was lower than in the control group (P < 0.05); no significant differences were observed at 48 or 72 h (Fig. 1a). No significant differences among groups were observed in ALP activity at days 7, 10, or 14 (Fig. 1b). Likewise, no significant differences in mineralization were observed by alizarin red staining at day 21 (Fig. 1c–d).
QG did not modulate matrix metalloproteinase expression or activity
No significant differences were observed in Mmp2 or Mmp9 gene expression at 24 or 48 h (Fig. 2a–b). Western blot densitometry and zymography likewise showed no significant differences in MMP-2 or MMP-9 protein expression or activity after 24 or 48 h of QG exposure (Fig. 2c–e and 2f–i, respectively).
Discussion
The use of plants for therapeutic purposes has attracted considerable research attention, particularly in Brazil because of its extensive biodiversity. In our study, the tested concentrations did not produce a sustained reduction in MTT metabolic activity, although a lower value was observed at 0.1 μg/mL after 24 h. We used the total extract rather than an isolated fraction because the literature reports antibacterial activity of QG.19 Regarding the expression or activity of specific molecules, including MMP-2 and MMP-9, no modulation was observed in MC3T3-E1 cells. Under physiological conditions, MMPs are normally expressed at lower levels to maintain homeostasis, whereas higher MMP expression has been associated with several cancer types and tumor development.31 Taken together, these findings do not provide evidence of osteogenic efficacy for QG extract in MC3T3-E1 cells. The absence of sustained metabolic suppression at the tested concentrations supports only preliminary in vitro compatibility and should not be interpreted as evidence of clinical safety.
MMP-2 and MMP-9 are expressed during osteoblast differentiation, and MMP-2 contributes to extracellular-matrix remodeling; its absence has been associated with impaired fracture repair.32,33 Conversely, MMP-9 appears to participate in osteoclast-based bone remodeling.5 An imbalance of these MMPs may contribute to pathological bone remodeling. Oliveira et al.24 reported increased MMP-14 and HIF1α expression in fibroblast and preosteoblast cells treated with 10.0 μg/mL of QG extract.
In our previous work,24 we identified gallic acid and flavonoids in the leaf extract of QG. BenSaad et al.34 suggested that gallic acid, ellagic acid, and punicalagin isolated from Punica granatum might be responsible for its potential anti-inflammatory effects. Additionally, bioactive plant molecules are known to exhibit various properties, such as anti-inflammatory, antiseptic, and antioxidant effects. Furthermore, these compounds may act through multiple cellular and molecular signaling pathways.35
ALP activity is an important early marker of cell differentiation, followed by the alizarin red mineralization assay. Our data showed no modulation of these processes by the extract (Fig. 1b–d). The literature reports that certain plants can modulate osteogenic processes; a review summarized that berberine, an ingredient in traditional Chinese medicine, showed increased osteogenic gene expression in a periodontitis experiment.36 A similar effect was not observed in this study. Recent reviews similarly indicate that plant-derived bioactives can influence osteoblastogenesis and bone regeneration through multiple signaling pathways, while emphasizing the need for mechanistic validation and cautious translation.37-40
Limitations of the study
This study was limited to in vitro experiments and specifically investigated the effect of QG on preosteoblast cell function, focusing on MMP-2 and MMP-9. Only one murine preosteoblast cell line was examined, and the functional assays were restricted to three low extract concentrations selected after preliminary screening indicated reduced metabolic activity at higher concentrations. Primary osteoblasts, osteoclast co-culture, inflammatory models, other osteogenic signaling pathways, and in vivo validation were not assessed. Accordingly, the findings cannot be generalized to other cell types or used to establish a complete dose-response relationship. We also note that the MTT assay measures metabolic activity and is not a direct measure of cell viability; therefore, other assays should be evaluated to support the safe use of QG.
Future directions
This study evaluated the effect of hydroalcoholic QG extract on osteoblast function, with a focus on MMPs. Future studies should evaluate a broader concentration range, additional primary or co-culture bone-cell models, and osteogenic signaling pathways, and should characterize standardized extract composition before translational applications are considered. Our previous work identified gallic acid and flavonoids in the extract.24
Conclusions
Except for the transient reduction in MTT metabolic activity at 0.1 μg/mL after 24 h, QG extract does not significantly alter the measured MC3T3-E1 functional outcomes at the tested concentrations. These findings do not demonstrate osteogenic efficacy or establish clinical safety; further dose-ranging and multi-model studies are needed.
Declarations
Funding
This study was supported by the São Paulo State Research Support Foundation (FAPESP; grant #2014/05425-2 to CKT, 2014/05234-2 to RCO, 2014/05299-7 to AGM, and 2014/20656-0 to GSNO).
Conflict of interest
The authors declare no conflicts of interest.
Author contributions
Study conception and design (CKT, RCO); data acquisition and analysis (CKT, FAO, LLS, GSNO, AAM, PPM, MRS, TJD, MLRS, AGM); data interpretation and manuscript review (MARB, ALD, RCO); funding acquisition (RCO); and manuscript drafting (CKT, RCO). All authors read and approved the final version of the manuscript.
Ethical statement
This study did not involve human participants or live animals. The MC3T3-E1 cell line was obtained from ATCC. Plant collection was approved by SISBIO under approval No. 39825-1.
Data sharing statement
The data are available from the corresponding author upon reasonable request.